Ann: Company Update , page-63

Robert called me a while ago.

Basically said there is no typical example that he can give me, they are all different.

Shell or backdoor listing same thing in his eyes and the value to exisitng holders depends on what sort of deal can be brokered.

Been lots of approaches some ridiculous to others with good potential, they are trying to focus on the best arrangement for shareholders and have time to do that.

There is a preference to keep it in the same sector, keeps it simple (but not essential). And a preference to do it quicker if possible to maximise the funds left in the business

1 Mil in the kitty with money coming in from the license deals is good, but the biggy to be resolved is bayer settlement, they need this finalised before they can talk details with anyone becasue it adds additional funds to the business.

Seems to be a genuine interest by all to maximise shareholder return out this mess.

Thats it, looks like the bayer settlement is key.